Fortrea Holdings (FTRE) Exchange Rate Effect (2022 - 2026)
Fortrea Holdings (FTRE) posted Exchange Rate Effect of -$2.1 million for Q1 2026, up 19.23% on a QoQ basis from -$2.6 million in Q4 2025, and down 175.0% year-over-year from $2.8 million in Q1 2025.
Fortrea Holdings (FTRE) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Fortrea Holdings' Exchange Rate Effect history runs 5 years deep, the most recent figure standing at -$2.1 million for Q1 2026.
- Quarterly Exchange Rate Effect fell 175.0% year-over-year to -$2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$400000.0 (up 75.0% YoY) and the FY2025 annual result came in at $4.5 million, up 167.16% from the prior year.
- Exchange Rate Effect was -$2.1 million for Q1 2026 at Fortrea Holdings, up from -$2.6 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $4.3 million in Q2 2025 and bottomed at -$6.3 million in Q4 2024.
- A 5-year average of -$264285.7 and a median of -$950000.0 in 2023 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2024 — Exchange Rate Effect tumbled 750.0% — and 2025, when it soared 352.94%.
- Fortrea Holdings' Exchange Rate Effect stood at $3.7 million in 2022, then retreated by 16.22% to $3.1 million in 2023, then slumped by 303.23% to -$6.3 million in 2024, then surged by 58.73% to -$2.6 million in 2025, then rose by 19.23% to -$2.1 million in 2026.
- Business Quant data shows FTRE's Exchange Rate Effect at -$2.1 million in Q1 2026, -$2.6 million in Q4 2025, and $4.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Fortrea Holdings | 1.83 Bn | 1.68 Bn | 123.60 Mn | -2.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.10 Mn |
| Mar 31, 2026 | -2.10 Mn |
| Dec 31, 2025 | -2.60 Mn |
| Dec 31, 2025 | -2.60 Mn |
| Jun 30, 2025 | 4.30 Mn |
| Jun 30, 2025 | 4.30 Mn |
| Mar 31, 2025 | 2.80 Mn |
| Mar 31, 2025 | 2.80 Mn |
| Dec 31, 2024 | -6.30 Mn |
| Dec 31, 2024 | -6.30 Mn |
| Sep 30, 2024 | 3.60 Mn |
| Sep 30, 2024 | 3.60 Mn |
| Jun 30, 2024 | -1.70 Mn |
| Jun 30, 2024 | -1.70 Mn |
| Mar 31, 2024 | -2.30 Mn |
| Mar 31, 2024 | -2.30 Mn |
| Dec 31, 2023 | 3.10 Mn |
| Dec 31, 2023 | 3.10 Mn |
| Sep 30, 2023 | -2.00 Mn |
| Sep 30, 2023 | -2.00 Mn |